Cancer Gene Therapy, Published online: 01 October 2026; doi:10.1038/s41417-026-01086-9 METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells
Huan Liu, ZhongCong Guo, Lan Li, YuXuan Dong, Nian Chen, ZhengTai Yuan. METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells. // Cancer Gene Therapy. – 2026. – DOI: 10.1038/s41417-026-01086-9. – URL: https://www.nature.com/articles/s41417-026-01086-9
Huan Liu, ZhongCong Guo, Lan Li, YuXuan Dong, Nian Chen, & ZhengTai Yuan (2026). METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells. Cancer Gene Therapy. https://doi.org/10.1038/s41417-026-01086-9
Huan Liu, et al. “METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells.” Cancer Gene Therapy, 2026. doi:10.1038/s41417-026-01086-9.
@article{Liu2026,
title = {METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells},
author = {Liu, Huan and Guo, ZhongCong and Li, Lan and Dong, YuXuan and Chen, Nian and Yuan, ZhengTai},
journal = {Cancer Gene Therapy},
year = {2026},
doi = {10.1038/s41417-026-01086-9},
url = {https://www.nature.com/articles/s41417-026-01086-9}
}
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials